—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Edwards Lifesciences Corp (EW) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for EW, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.46 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How EW has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.46 — tends to move with bonds for every 1% move in TLT (20+ year Treasuries), Edwards Lifesciences Corp moved 0.46% on average · correlation 0.17 · higher than 47% of US names
  • Beta, last 3 months 0.26 less rate-sensitive lately than over the year
  • On the 10 worst bond days −0.45% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.26% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against EW on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Edwards Lifesciences Corp

EW in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Edwards Lifesciences makes devices to treat heart valve disease, sold in the United States, Europe, Japan and elsewhere. Its main products are transcatheter heart valves under the Sapien range, used to replace the aortic valve without open surgery, plus the Pascal and Evoque devices, which repair or replace mitral and tricuspid valves. It also sells surgical valves under the Inspiris and Konect Resilia names for open-heart procedures, reaching hospitals through its own sales force and independent distributors. The company is based in Irvine, California, and has been listed since 2000.
Where it sits in the stack
Edwards Lifesciences carries no seat in Rubin, the diary's AI build-out index; it sits in our Healthcare sleeve, under Medical Devices, alongside other cardiovascular device makers.
Who it is priced against
The diary's peer group is not set for Edwards; the market most often compares it with Medtronic in heart valve therapies.
Why Closelooknet tracks it
It holds a seat in the S&P 500 but carries no Rubin index seat and no Closelooknet score; the diary has not yet quoted it.
What the diary watches
The diary watches for regulatory approvals or new indications that widen the use of its transcatheter valve platforms.

Edwards Lifesciences Corp (EW) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Edwards Lifesciences Corp (EW)?

Edwards Lifesciences Corp trades as EW on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is EW in a Closelooknet index?

Not currently — Edwards Lifesciences Corp is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does EW trade against its moving averages?

Pullback inside an uptrend stack: Trades -2.3% vs the 50-day and +1.4% vs the 200-day average, 10.4% below the 52-week high and +19.3% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Edwards Lifesciences Corp trade when bond yields rise?

Over the past year Edwards Lifesciences Corp had a beta of 0.46 to TLT, the long-dated Treasury fund — it tends to move with bonds, higher than 47% of US names. On the 10 sessions in which long bonds fell most it moved −0.45% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Edwards Lifesciences Corp do?

Edwards Lifesciences makes devices to treat heart valve disease, sold in the United States, Europe, Japan and elsewhere. Its main products are transcatheter heart valves under the Sapien range, used to replace the aortic valve without open surgery, plus the Pascal and Evoque devices, which repair or replace mitral and tricuspid valves. It also sells surgical valves under the Inspiris and Konect Resilia names for open-heart procedures, reaching hospitals through its own sales force and independent distributors. The diary's peer group is not set for Edwards; the market most often compares it with Medtronic in heart valve therapies.

Where does Edwards Lifesciences Corp sit in the AI build-out?

Edwards Lifesciences carries no seat in Rubin, the diary's AI build-out index; it sits in our Healthcare sleeve, under Medical Devices, alongside other cardiovascular device makers. It holds a seat in the S&P 500 but carries no Rubin index seat and no Closelooknet score; the diary has not yet quoted it.

What does this page show?

A live price chart with SMA overlays and drawing tools for EW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.